A new study suggests that the role of yeast, the world’s most basic eukaryotic unicellular organism, may pave the way for the development of novel, more effective therapies for congenital diseases.
A new study suggests that the role of yeast, the world’s most basic eukaryotic unicellular organism, may pave the way for the development of novel, more effective therapies for congenital diseases.